Condition: Breast Ductal Carcinoma In Situ · COVID-19 Infection · Hereditary Breast Carcinoma · Sponsor: M.D. Anderson Cancer Center
This study investigates the impact of COVID-19 pandemic on out-of-pocket costs, lost wages, and unemployment in patients with breast cancer undergoing breast surgery. Post-mastectomy reconstructive patients are at high risk for financial toxicity (adverse effects of escalating health care cost on well-being). The goal of this study is to collect information about financial costs patients may have as a result of surgical treatment for cancer with or without breast reconstruction and to learn if COVID-19 affects patient costs of breast reconstruction. This may help researchers demonstrate the financial consequences of undergoing breast surgery.
This description comes directly from the study's public registry record.
Carrie Chu, MD · 713-794-1247 · ckchu@mdanderson.org
Always discuss trial participation with your own doctor first.
| MD Anderson in The Woodlands | Conroe, Texas, United States | Recruiting |
| M D Anderson Cancer Center | Houston, Texas, United States | Recruiting |
| MD Anderson League City | League City, Texas, United States | Recruiting |
| MD Anderson in Sugar Land | Sugar Land, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04169542